Skip to main content
. 2020 Dec 8;12:12603–12612. doi: 10.2147/CMAR.S253452

Figure 1.

Figure 1

NLIPMT expression was downregulated in ESCC and predict poor survival of ESCC patients. (A) QRT-PCR was performed to detect the expression of NLIPMT in ESCC and non-tumor tissues. Expression data were compared by performing paired t-test. (B) Survival analysis was performed by grouping the 58 ESCC patients into high and low NLIPMT level groups (n = 29), followed by survival cure plotting and comparison by K-M plotter and Log rank test, respectively. *p < 0.05.